These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10676759)

  • 1. Neurotoxic effects of endocrine disruptors.
    Laessig SA; McCarthy MM; Silbergeld EK
    Curr Opin Neurol; 1999 Dec; 12(6):745-51. PubMed ID: 10676759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition, classification and mechanism of action of endocrine disrupting chemicals.
    Wuttke W; Jarry H; Seidlova-Wuttke D
    Hormones (Athens); 2010; 9(1):9-15. PubMed ID: 20363717
    [No Abstract]   [Full Text] [Related]  

  • 3. The endocrine disrupters: a major medical challenge.
    Amaral Mendes JJ
    Food Chem Toxicol; 2002 Jun; 40(6):781-8. PubMed ID: 11983272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationships for endocrine disruptors: what we know and what we don't know.
    Lucier GW
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):34-5. PubMed ID: 9339476
    [No Abstract]   [Full Text] [Related]  

  • 5. Environmental factors and nosology of the endocrine system.
    Dacou-Voutetakis C
    Hormones (Athens); 2010; 9(1):7-8. PubMed ID: 20363716
    [No Abstract]   [Full Text] [Related]  

  • 6. Animal models of endocrine disruption.
    Patisaul HB; Fenton SE; Aylor D
    Best Pract Res Clin Endocrinol Metab; 2018 Jun; 32(3):283-297. PubMed ID: 29779582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine disruptors.
    Pombo M; Castro-Feijóo L
    J Pediatr Endocrinol Metab; 2005 Dec; 18 Suppl 1():1145-55. PubMed ID: 16398443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds.
    Ottinger MA; Lavoie E; Thompson N; Barton A; Whitehouse K; Barton M; Abdelnabi M; Quinn M; Panzica G; Viglietti-Panzica C
    Brain Res Rev; 2008 Mar; 57(2):376-85. PubMed ID: 18006066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of endocrine disruptors: approaches, issues, and uncertainties.
    Chen CW
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():20-3. PubMed ID: 11820607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive effects of endocrine-disrupting chemicals in animals.
    Schantz SL; Widholm JJ
    Environ Health Perspect; 2001 Dec; 109(12):1197-206. PubMed ID: 11748026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental estrogens and endocrine disruption: importance of comparative endocrinology.
    Foster WG
    Endocrinology; 2008 Sep; 149(9):4267-8. PubMed ID: 18511513
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental neurotoxicology of endocrine disruptors and pesticides: identification of information gaps and research needs.
    Tilson HA
    Environ Health Perspect; 1998 Jun; 106 Suppl 3(Suppl 3):807-11. PubMed ID: 9646041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A toxicologically based weight-of-evidence methodology for the relative ranking of chemicals of endocrine disruption potential.
    Calabrese EJ; Baldwin LA; Kostecki PT; Potter TL
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):36-40. PubMed ID: 9339477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental endocrine disrupters.
    Toppari J
    Sex Dev; 2008; 2(4-5):260-7. PubMed ID: 18987500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The hypothesis of environmental causes of damage to the endocrine system: science of sensationalism?].
    Ezratty V
    Presse Med; 1999 Apr; 28(14):758-63. PubMed ID: 10230419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental exposures that affect the endocrine system: public health implications.
    DeRosa C; Richter P; Pohl H; Jones DE
    J Toxicol Environ Health B Crit Rev; 1998; 1(1):3-26. PubMed ID: 9487091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency matters: thresholds govern endocrine activity.
    Borgert CJ; Baker SP; Matthews JC
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):83-8. PubMed ID: 23838262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond screening: problems and prospects for risk characterization of endocrine disruptors.
    Rhomberg L
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):74-9. PubMed ID: 9339483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New modes of action for endocrine-disrupting chemicals.
    Tabb MM; Blumberg B
    Mol Endocrinol; 2006 Mar; 20(3):475-82. PubMed ID: 16037129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocrine effects of nonhormonal antineoplastic therapy.
    Yeung SC; Chiu AC; Vassilopoulou-Sellin R; Gagel RF
    Endocr Rev; 1998 Apr; 19(2):144-72. PubMed ID: 9570035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.